Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Aberrant expression of microRNA in polycythemia vera.

Haematologica - 1 Jul 2008

Bruchova Hana, Merkerova Michaela, Prchal Josef T

Abstract excerpt

BACKGROUND: Polycythemia vera is a clonal hematopoietic stem cell disorder in which the JAK2 V617F mutation is observed in >95% of patients, but an as yet unidentified process appears to initiate the clonal expansion of hematopoiesis. Because microRNA regulate hematopoietic differentiation, we hy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hematopoiesis
Share to Janus Kinase 2
Share to Cell Lineage

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Granulocytes

Share to Leukocytes, Mononuclear

Share to MicroRNAs

Share to Polycythemia Vera

Share to Primary Myelofibrosis

Source

Identifiers

PMID: 18508790
DOI: 10.3324/haematol.12706

Genes

JAK2
HMGA2
IRAK2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18508790-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Aberrant expression of microRNA in polycythemia vera.PMID 18508790Read ↗

Micro<scp>RNA</scp>s in myeloproliferative neoplasmsSemantic proximity Read ↗

MicroRNA expression and JAK2 allele burden in bone marrow trephine biopsies of polycythemia vera, essential thrombocythemia and early primary myelofibrosis.Semantic proximity Read ↗

Regulated expression of microRNAs in normal and polycythemia vera erythropoiesisSemantic proximity Read ↗

Overexpression of microRNA-16-2 contributes to the abnormal erythropoiesis in polycythemia veraSemantic proximity Read ↗

Molecular profiling of peripheral blood cells from patients with polycythemia vera and related neoplasms: Identification of deregulated genes of significance for inflammation and immune surveillanceSemantic proximity Read ↗

Expression analysis of microRNA-125 in patients with polycythemia vera and essential thrombocythemia and correlation with JAK2 allele burden and laboratory findings.Semantic proximity Read ↗

Transcriptional profiling of polycythemia vera identifies gene expression patterns both dependent and independent from the action of JAK2V617F.Semantic proximity Read ↗

Two clinical phenotypes in polycythemia vera.Semantic proximity Read ↗

Gene and microRNA analysis of neutrophils from patients with polycythemia vera and essential thrombocytosis: down-regulation of micro RNA-1 and -133aSemantic proximity Read ↗

Polycythemia vera erythroid precursors exhibit increased proliferation and apoptosis resistance associated with abnormal RAS and PI3K pathway activation.Semantic proximity Read ↗

Dysregulation of the <i><scp>MIRLET</scp>7</i>/<i><scp>HMGA</scp>2</i> axis with methylation of the <i><scp>CDKN</scp>2A</i> promoter in myeloproliferative neoplasmsSemantic proximity Read ↗

Role of JAK2 V617F mutation and aberrant expression of microRNA-143 in myeloproliferative neoplasms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.